Immunotherapy: Therapeutic potential of genetically modified HBV-specific T cells for chronic HBV infection and HBV-related HCC

Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):61. doi: 10.1038/nrgastro.2010.221.
No abstract available